Company Filing History:
Years Active: 2022
Title: HeeJi Lim: Innovator in Zika Virus Research
Introduction
HeeJi Lim is a notable inventor based in Chungcheongbuk-do, South Korea. He has made significant contributions to the field of virology, particularly in the development of vaccines against the Zika virus. His innovative work has the potential to enhance public health responses to viral outbreaks.
Latest Patents
HeeJi Lim holds a patent for a recombinant antigen derived from the Zika virus E protein. This invention relates to a polynucleotide encoding Zika virus E protein domain III, which can be used to create a DNA vaccine composition. The vaccine aims to induce an immune response to the Zika virus by effectively expressing the Zika virus antigen protein. Additionally, the patent includes a method for preparing a neutralizing antibody against the Zika virus using the polynucleotide.
Career Highlights
HeeJi Lim is affiliated with the Korea Center for Disease Control and Prevention. His work at this institution underscores his commitment to advancing public health through innovative research and development. His contributions are vital in the ongoing efforts to combat viral diseases.
Collaborations
HeeJi Lim has collaborated with notable colleagues, including You-Jin Kim and Hyun Ju In. These partnerships enhance the research efforts and broaden the impact of their findings in the scientific community.
Conclusion
HeeJi Lim's work in developing a recombinant antigen for the Zika virus represents a significant advancement in vaccine research. His contributions are crucial for improving public health responses to viral infections.